BPC 157: Experimental Peptide Creates Risk for Athletes The Peptide Boom Is Getting Out of Hand The Atlantic The peptide problem: Hype is outrunning the evidence The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular fda warning bpc 157 peptide products New Details 157 Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law